miR-149-3p Enhances Drug Sensitivity of AML Cells by Inhibiting Warburg Effect Through PI3K/AKT Pathway
Cell Biochemistry and Biophysics · 2024
DOI: 10.1007/s12013-024-01412-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Xi Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hemotology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: MicroRNAs, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hemotology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China.
- Department of Hemotology, the Second Affiliated Hospital of Harbin Medical University, Harbin, China. wangwei1262023@126.com.
Zitieren
APA
Chen, X., Song, Y., Tian, Y., Dong, X., Chang, Y., & Wang, W. (2024). miR-149-3p Enhances Drug Sensitivity of AML Cells by Inhibiting Warburg Effect Through PI3K/AKT Pathway. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01412-8
Vancouver
Chen X, Song Y, Tian Y, Dong X, Chang Y, Wang W. miR-149-3p Enhances Drug Sensitivity of AML Cells by Inhibiting Warburg Effect Through PI3K/AKT Pathway. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01412-8
BibTeX
@article{Chen2024,
author = {Chen, Xi and Song, Yan and Tian, Yaoyao and Dong, Xiushuai and Chang, Yuying and Wang, Wei},
title = {miR-149-3p Enhances Drug Sensitivity of AML Cells by Inhibiting Warburg Effect Through PI3K/AKT Pathway},
journal = {Cell Biochemistry and Biophysics},
year = {2024},
doi = {10.1007/s12013-024-01412-8}
}
EUVIMED